With Treatment
New York Center For Living Inc Op is an addiction treatment center located at 224-226 East 52nd Street in the 10022 zip code in New York, NY. It is operated by a private non-profit organization. New York Center For Living Inc Op provides naltrexone administration, prescribes suboxone and buprenorphine maintenance. Some of the treatment approaches used by New York Center For Living Inc Op include DBT, anger management and matrix model. New York Center For Living Inc Op provides IOT, regular outpatient drug treatment and outpatient methadone/buprenorphine/naltrexone treatment. It also provides inpatient treatment for co-occurring mental health and drug use disorders and residential drug use treatment.
Address: 224-226 East 52nd Street, New York, NY 10022
Here are the full facility listing details on New York Center for Living Inc OP in New York, NY:
Types of Care:
Service Settings:
Opioid Medications used in Treatment:
External Opioid Medications Source:
Type of Alcohol Use Disorder Treatment:
External Source of Medications Used for Alcohol Use Disorder Treatment:
Type Of Treatment:
Pharmacotherapies:
Treatment Approaches:
Facility Ownership:
License/Certification/Accreditation:
Payment/Insurance/Funding Accepted:
Payment Assistance Available:
Special Programs/ Population Groups Supported:
Assessment/Pre-treatment:
Screening & Testing:
Transitional Services:
Ancillary Services:
Counseling Services and Education:
Tobacco/Screening Services:
Facility Smoking Policy:
Age Groups Accepted:
Gender Accepted:
Phone #: 212-712-8800
Call (877) 539-5579 for 24/7 help with treatment.
In New York, NY, you can find a variety of addiction treatment programs, including inpatient rehab, outpatient rehab, detoxification services, and dual-diagnosis programs. The specific program that's right for you depends on your needs and the severity of your addiction.
When choosing a drug rehab center in New York, consider factors such as the facility's accreditation, the qualifications of the staff, the treatment methods used, the cost, and whether the center offers aftercare and relapse prevention services. It's important to select a rehab center that aligns with your specific needs and preferences.
The duration of drug rehab at New York Center for Living Inc OP and in other addiction treatment centers in New York varies depending on the type of program and the individual's progress. In general, it can range from 30 days to 90 days or even longer for more intensive treatment. Aftercare and ongoing therapy may continue for several months to support long-term recovery.
Common therapies and treatments in New York drug rehab programs include individual counseling, group therapy, cognitive-behavioral therapy (CBT), family therapy, and holistic approaches like yoga and meditation. Medication-assisted treatment (MAT) may also be offered for specific addictions.
The cost of drug rehab in New York Center for Living Inc OP and in general in New York varies widely based on factors such as the type of program, the amenities provided, and the location of the facility. Inpatient rehab tends to be more expensive than outpatient services. Many rehab centers accept insurance, which can help cover some or all of the costs. It's essential to contact New York Center for Living Inc OP and other treatment centers for accurate pricing information.
Yes, in New York and other locations in New York, there are specialized drug rehab programs for various populations, including women, men, veterans, LGBTQ individuals, seniors and adolescents. These programs are tailored to address the unique needs and challenges faced by these specific groups, providing more focused and supportive care.
After completing drug rehab in New York, you can access various forms of support, such as alumni programs, 12-step meetings (e.g., Narcotics Anonymous, Alcoholics Anonymous), and ongoing counseling or therapy. Many rehab centers provide aftercare services to help you maintain your sobriety and prevent relapse.
Other drug and rehab centers within 75 miles of New York Center for Living Inc OP: